Conference Coverage

New remote monitoring system lessens symptoms in head and neck cancer


 

REPORTING FROM ASCO 2018


The groups fared essentially the same with respect to scores assessing interference of symptoms with activities of daily living.

Dr. Peterson disclosed that she had no relevant conflicts of interest. The study received funding from the National Institutes of Health.

SOURCE: Peterson et al. ASCO 2018, Abstract 6063.

Pages

Recommended Reading

Management of tonsillar carcinoma with advanced radiation therapy and chemotherapy techniques
MDedge Hematology and Oncology
Cancer patients with TKI-induced hypothyroidism had better survival rates
MDedge Hematology and Oncology
ASCO larynx-preservation guidelines reflect important practice changes
MDedge Hematology and Oncology
New and improved classifiers may sharpen thyroid nodule diagnosis
MDedge Hematology and Oncology
Pembrolizumab plus SBRT shows promise for advanced solid tumors
MDedge Hematology and Oncology
Recurrent head and neck cancer presenting as a large retroperitoneal mass
MDedge Hematology and Oncology
When it comes to thyroid cancer follow-up, serum microRNA profiles have earned new respect
MDedge Hematology and Oncology
Probe linked to smartphone found effective in diagnosing oral cancer
MDedge Hematology and Oncology
Resolution of refractory pruritus with aprepitant in a patient with microcystic adnexal carcinoma
MDedge Hematology and Oncology
FDA approves dabrafenib/trametinib for BRAF-positive anaplastic thyroid cancer
MDedge Hematology and Oncology